Caelum Biosciences
Caelum Biosciences is a New York-based biotechnology company that develops and commercializes drugs for the treatment of AL amyloidosis and hematologic disorders.
Business Model:
Revenue: $5.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Caelum Biosciences Information
Caelum Biosciences was acquired by
AstraZeneca.
The acquisition happend on 2021-09-29.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 2 Gansevoort St
City: New York
State: NY
Zip: 10014
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$40M
Social
Metrics
5,076,969Website Global Rank
1,618Website Monthly Traffic
Twitter Followers
Description
Caelum Biosciences is a New York-based biotechnology company that develops and commercializes drugs for the treatment of AL amyloidosis and hematologic disorders.
Contact Phone:
+17816524500
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Equity | $30M |
Alexion Pharmaceuticals, Inc |
7/2017 | Debt | $9.9M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
